Brevan Howard Capital Management’s Fractyl Health GUTS Stock Holding History
Bought
Maintained
Sold
Other funds holding GUTS
NCM
6CM
PFCS
VCM
CCM
GCGM
DMC
MC
WP
Brevan Howard Capital Management's GUTS Position: Q1 2026 in Review
Brevan Howard Capital Management reduced its Fractyl Health (GUTS) stake by 50% in Q1 2026, selling an estimated $214K and leaving 232,369 shares worth $99.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2025.
Brevan Howard Capital Management first reported a position in GUTS in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.05M in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.
- Brevan Howard Capital Management held 232,369 shares of Fractyl Health worth $99.2K as of Q1 2026.
- Brevan Howard Capital Management sold 232,369 Fractyl Health shares in Q1 2026, an estimated $214K.
- Fractyl Health made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #2025 holding.
- Brevan Howard Capital Management first reported a position in Fractyl Health in Q4 2025 and has held it in 2 quarters since.
- Brevan Howard Capital Management's Fractyl Health position peaked at $1.05M in Q4 2025.
- 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.
Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.